Regarding unexpected severe and life-threatening donor-transmitted viral infections and use of high-risk behavior donors

Liver Transplantation

Volumn 14, Issue 11, 2008, Pages 1564-1568

  Kusne, Shimon ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES VACCINE;

CAUSE OF DEATH; EDITORIAL; ENCEPHALITIS; GRAFT RECIPIENT; HIGH RISK BEHAVIOR; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ORGAN DONOR; ORGAN TRANSPLANTATION; PATIENT SAFETY; PREVALENCE; PRIORITY JOURNAL; RABIES; RABIES VIRUS; VIRUS DETECTION; VIRUS INFECTION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

ADULT; AGED; DELTARETROVIRUS INFECTIONS; FEMALE; HIV INFECTIONS; HUMANS; LIVER TRANSPLANTATION; LYMPHOCYTIC CHORIOMENINGITIS; MALE; MIDDLE AGED; RABIES; RISK-TAKING; TISSUE DONORS; VIRUS DISEASES; WEST NILE FEVER;

EID: 57849168984     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21633     Document Type: Editorial

References (28)

1. Ahn J, Cohen S. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl 2008;14:1603-1608.
2. Gottesdiener KM. Transplanted infections: donor-to-host. Ann Intern Med 1989;110:1001-1016.
3. Wilck M, Fishman JA. The challenges of infection in transplantation: donor-derived infections. Curr Opin Organ Transplant 2005;10:301-306.
4. Centers for Disease Control and Prevention. West Nile virus infection in organ donor and transplant recipients - Georgia and Florida, 2002. MMWR 2002; Public Health Dispatch September 6, 2002.
5. Centers for Disease Control and Prevention. Detection of West Nile virus in blood donations - United States, 2003. MMWR Surveill Summ 2003;52:769-772.
6. Iwamoto M, Jernigan DB, Guasch A, Trepka MJ, Blackmore CG, Hellinger WC, et al., Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003;348:2196-2203.
7. Centers for Disease Control and Prevention. West Nile virus infection in organ transplant recipients - New York and Pennsylvania, August-September, 2005. MMWR Surveill Summ2005;54(dispatch):1-3.
8. Health Resources and Services Administration. A special announcement from HRSA regarding West Nile Virus. Available at: http://www.unos.org/ news. Accessed June 2008.
9. Srinivasan A, Burton EC, Kuehnert MJ, Rupprecht C, Sutker WL, Ksiazek TG, et al., Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005;352:1103-1111.
10. Rabies in patients who received organ transplants in Germany. CDR Wkly (Online) 2005;15:News.
11. Bronnert J, Wilde H, Tepsumethanon V, Lumlertdacha B, Hemachudha T. Review article: organ transplantation and rabies transmission. J Travel Med 2007;14:177-180.
12. De Serres G, Dallaire F, Cote M, Skowronski DM. Bat rabies in the United States and Canada from 1950 through 2007: human cases with and without bat contact. Clin Infect Dis 2008;46:1329-1337.
13. Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A, Marty FM, et al., Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006;354:2235-2249.
14. Centers for Disease Control and Prevention. Lymphocytic choriomeningitis virus infection in organ transplant recipients - Massachusetts, Rhode Island, 2005. MMWR Surveill Summ 2005;54:537-539.
15. Palacios G, Druce J, Du L, Tran T, Birch C, Briese T, et al. A new arenavirus in a cluster of fatal transplant-associated disease. N Engl J Med 2008;358:991-998.
16. Centers for Disease Control and Prevention. Interim guidance for minimizing risk for human lymphocytic choriomeningitis virus infection associated with pet rodents. interim guidance. MMWR Surveill Summ 2005;54:747-749.
17. Centers for Disease Control and Prevention. Update: interim guidance for minimizing risk for human lymphocytic choriomeningitis virus infection associated with pet rodents. MMWR Surveill Summ 2005;54:799-801.
18. Gonzalez-Perez MP, Munoz-Juarez L, Cardenas F, Imirizaldu JJZ, Carraceja JC, Garcia-Saiz A. Human T-cell leukemia virus type I infection in various recipients of transplant from the same donor. Transplantation 2003; 75:1006-1011.
19. Centers for Disease Control and Prevention. Recommendations for counseling persons infected with human Tlymphotrophic virus, type I and II. MMWR Recomm Rep 1993;42(RR-9):1-13.
20. Shames BD, D'Alessandro AM, Sollinger HW. Human T-cell lymphotrophic virus infection in organ donors: a need to reassess policy? Am J Transplant 2002;2:658-663.
21. OPTN: Organ Procurement and Transplantation Network. Available at: http://www.optn.org/latestData/rptData-.asp. Accessed May 2008.
22. Attia M, Silva MA, Mirza DF. Review: the marginal liver donor - an update. Transpl Int 2008;21:713-724.
23. Centers for Disease Control and Prevention. Guidelines for preventing transmission of human Immunodeficiency Virus through transplantation of human tissue and organs. MMWR Recomm Rep 1994;43(RR-8):1-17.
24. United Network for Organ Sharing. Summary of actions taken at the OPTN/ UNOS Executive Committee Meeting - December 18, 2007. Available at: http://www.unos.org. Accessed August 2008.
25. Molmenti EP, Smith DM, Molmenti H, Fasola CG, Aguanno JJ, Savino AC, et al. Unusually high incidence of positive HTLVI/II results among young female organ donors in the peripartum period. Dig Dis Sci 2002;47:2383-2385.
26. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid amplification testing. N Engl J Med 2004;351:760-768.
27. Aswad S, Khan NS, Comanor L, Chinchilla C, Corado L, Mone T, et al. Role of nucleic acid testing in cadaver organ donor screening: detection of hepatitis C virus RNA in seropositive and seronegative donors. J Viral Hepat 2005; 12:627-634.
28. U.S. Food and Drug Administration. Guidance for Industry. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps)). August 2007. Available at: http://www.fda.gov/cber/gdlns/tissdonor.pdf. Accessed June 2008.